The ‘weight loss trade’ has stalled. What it will take to revive investor interest
The article discusses the challenges faced by pharmaceutical companies Novo Nordisk and Eli Lilly in the weight loss medication market, particularly with their drugs Wegovy and Zepbound. Here are 3 highlights from the article: 1. Novo Nordisk and Eli Lilly initially saw great investor excitement and stock price surges due to the promising weight loss […]
